The Oncology Institute, Inc. Warrant (TOIIW) EPS by Year
TOIIW
The Oncology Institute, Inc. Warrant lost $0.54 per diluted share in fiscal year 2025. This represents an increase of 23.9% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters The Oncology Institute, Inc. Warrant has filed alongside them.
FY2025 annual
EPS (Diluted)-$0.54
YoY+23.9%
Source SEC Filings (10-K/10-Q)Latest period Q2 FY2026, ended Jun 30, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
TOIIW EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
More The Oncology Institute, Inc. Warrant financials
What was The Oncology Institute, Inc. Warrant's diluted earnings per share in fiscal year 2025?
The Oncology Institute, Inc. Warrant lost $0.54 per diluted share in fiscal year 2025.
How fast is The Oncology Institute, Inc. Warrant's diluted earnings per share growing?
The Oncology Institute, Inc. Warrant (TOIIW) diluted earnings per share rose by 23.9% year over year, from -$0.71 to -$0.54 in fiscal year 2025.
How has The Oncology Institute, Inc. Warrant's diluted earnings per share changed over the years?
Across the 6 fiscal years this page covers, The Oncology Institute, Inc. Warrant (TOIIW) diluted earnings per share went from -$0.24 in fiscal year 2020 to -$0.54 in fiscal year 2025.
What was The Oncology Institute, Inc. Warrant's diluted earnings per share in the most recent quarter?
The Oncology Institute, Inc. Warrant (TOIIW) reported -$0.08 in diluted earnings per share in Q2 2026. This represents an increase of 46.7% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what The Oncology Institute, Inc. Warrant (TOIIW) reported on that line in every period on record.
